Metformin Treatment Among Men With Diabetes and the Risk of Prostate Cancer: A Population-Based Historical Cohort Study
Authors:
- Laurence S FreedmanLFLaurence S Freedman
- Nirit AgayNANirit Agay
- Ruth FarmerRFRuth Farmer
- Havi MuradHMHavi Murad
- Liraz OlmerLOLiraz Olmer
- Rachel DanknerRDRachel Dankner
Open Access
- 10 December 2021
- journal article
- research article
- Published by Oxford University Press (OUP) in American Journal of Epidemiology
- Vol. 191 (4) , 626-635
Abstract
There is conflicting evidence regarding the association between metformin treatment and prostate cancer risk in diabetic men. We investigated this association in a population-based Israeli cohort of 145,617 men aged 21–89 years with incident diabetes who were followed over the period 2002–2012. We implemented a time-dependent covariate Cox model, using weighted cumulative exposure to relate metformin history to prostate cancer risk, adjusting for use of other glucose-lowering medications, age, ethnicity, and socioeconomic status. To adjust for time-varying glucose control variables, we used inverse probability weighting of a marginal structural model. With 666,553 person-years of follow-up, 1,592 men were diagnosed with prostate cancer. Metformin exposure in the previous year was positively associated with prostate cancer risk (per defined daily dose; without adjustment for glucose control, hazard ratio (HR) = 1.53 (95% confidence interval (CI): 1.19, 1.96); with adjustment, HR = 1.42 (95% CI: 1.04, 1.94)). However, exposure during the previous 2–7 years was negatively associated with risk (without adjustment for glucose control, HR = 0.58 (95% CI: 0.37, 0.93); with adjustment, HR = 0.60 (95% CI: 0.33, 1.09)). These positive and negative associations with previous-year and earlier metformin exposure, respectively, need to be confirmed and better understood.Keywords
This publication has 24 references indexed in Scilit:
- Metformin Use and All-Cause and Prostate Cancer–Specific Mortality Among Men With DiabetesJournal of Clinical Oncology, 2013
- Vitamin D Levels for Preventing Acute Coronary Syndrome and Mortality: Evidence of a Nonlinear AssociationThe Journal of Clinical Endocrinology & Metabolism, 2013
- Methods for dealing with time‐dependent confoundingStatistics in Medicine, 2012
- Metformin and the Risk of CancerDiabetes Care, 2012
- Lower Risk of Cancer in Patients on Metformin in Comparison With Those on Sulfonylurea DerivativesDiabetes Care, 2011
- Glucose-lowering agents and the patterns of risk for cancer: a study with the General Practice Research Database and secondary care dataDiabetologia, 2011
- Assessing socioeconomic health care utilization inequity in Israel: impact of alternative approaches to morbidity adjustmentBMC Public Health, 2011
- Flexible modeling of the cumulative effects of time‐dependent exposures on the hazardStatistics in Medicine, 2009
- Constructing Inverse Probability Weights for Marginal Structural ModelsAmerican Journal of Epidemiology, 2008
- Impact of mis‐specification of the treatment model on estimates from a marginal structural modelStatistics in Medicine, 2008